argenx SE (ARGNF)
936.00
0.00 (0.00%)
USD |
OTCM |
Oct 06, 16:00
argenx Enterprise Value : 57.89B for Oct. 6, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 06, 2026 | 57.89B |
| October 05, 2026 | 57.89B |
| October 02, 2026 | 57.89B |
| October 01, 2026 | 57.89B |
| September 30, 2026 | 58.85B |
| September 29, 2026 | 58.85B |
| September 28, 2026 | 58.85B |
| September 25, 2026 | 62.49B |
| September 24, 2026 | 62.49B |
| September 23, 2026 | 62.49B |
| September 22, 2026 | 62.49B |
| September 21, 2026 | 62.49B |
| September 18, 2026 | 62.49B |
| September 17, 2026 | 62.49B |
| September 16, 2026 | 62.49B |
| September 15, 2026 | 62.49B |
| September 14, 2026 | 62.49B |
| September 11, 2026 | 62.49B |
| September 10, 2026 | 62.49B |
| September 09, 2026 | 62.49B |
| September 08, 2026 | 62.49B |
| September 04, 2026 | 62.74B |
| September 03, 2026 | 62.74B |
| September 02, 2026 | 62.74B |
| September 01, 2026 | 62.74B |
| Date | Value |
|---|---|
| August 31, 2026 | 62.74B |
| August 28, 2026 | 63.09B |
| August 27, 2026 | 63.09B |
| August 26, 2026 | 63.09B |
| August 25, 2026 | 61.55B |
| August 24, 2026 | 61.55B |
| August 21, 2026 | 61.55B |
| August 20, 2026 | 61.55B |
| August 19, 2026 | 61.55B |
| August 18, 2026 | 61.55B |
| August 17, 2026 | 60.45B |
| August 14, 2026 | 53.69B |
| August 13, 2026 | 53.69B |
| August 12, 2026 | 53.69B |
| August 11, 2026 | 53.69B |
| August 10, 2026 | 53.50B |
| August 07, 2026 | 53.50B |
| August 06, 2026 | 53.50B |
| August 05, 2026 | 53.50B |
| August 04, 2026 | 53.50B |
| August 03, 2026 | 53.50B |
| July 31, 2026 | 53.50B |
| July 30, 2026 | 53.50B |
| July 29, 2026 | 53.50B |
| July 28, 2026 | 53.50B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| ProQR Therapeutics NV | 114.03M |
| Pharming Group NV | 653.60M |
| NewAmsterdam Pharma Co. NV | 1.985B |
| Agenus, Inc. | 583.85M |
| Amgen, Inc. | 260.96B |
Enterprise Value Related Metrics
| Earnings Yield | 2.81% |
| Operating Earnings Yield | 2.46% |
| Normalized Earnings Yield | 2.806 |